Paul Weiden
Management
Ascend Biopharmaceuticals
Australia
Biography
Dr. Paul Weiden has worked for biotechnology firms involved in developing chemotherapeutic agents and cellular immunotherapy of cancer since 2001. During the previous 20 years, he was a member of the Section of Haematology-Oncology at Virginia Mason Medical Centre, Seattle, Washington. He served as Principal Investigator of the Community Clinical Oncology Program (CCOP) where he gained experience in cooperative group trials and as the Principal Investigator of the Cancer Clinical Trials Unit responsible for the design and conduct of phase 1/2 trials involving radio-labelled monoclonal antibodies. MD, Harvard Medical School.
Research Interest
Business
